Page 3 - Exscientia News Today

OXFORD, England, October 16, 2023--Exscientia plc (Nasdaq: EXAI) today announced two abstracts to be presented at the upcoming European Society for Medical Oncology (ESMO) Congress 2023 from October 20-24, 2023 in Madrid, Spain.

Exscientia plc (NASDAQ:EXAI – Get Free Report)’s share price traded down 9.1% during mid-day trading on Tuesday after Barclays lowered their price target on the stock from $12.00 to $10.00. Barclays currently has an overweight rating on the stock. Exscientia traded as low as $5.31 and last traded at $5.32. 310,413 shares traded hands during […]

Exscientia (NASDAQ:EXAI – Free Report) had its target price trimmed by Morgan Stanley from $14.00 to $7.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has an equal weight rating on the stock. Other analysts also recently issued research reports about the company. Berenberg Bank initiated coverage on […]

Key Insights Exscientia's significant individual investors ownership suggests that the key decisions are influenced by...

Exscientia plc (NASDAQ:EXAI – Get Free Report)’s stock price fell 2.6% during mid-day trading on Tuesday . The company traded as low as $4.45 and last traded at $4.45. 30,025 shares changed hands during trading, a decline of 93% from the average session volume of 416,585 shares. The stock had previously closed at $4.57. Analysts […]

Exscientia plc (NASDAQ:EXAI – Get Free Report) gapped down prior to trading on Wednesday after Bank of America lowered their price target on the stock from $16.00 to $11.00. The stock had previously closed at $4.59, but opened at $4.49. Exscientia shares last traded at $4.48, with a volume of 38,376 shares trading hands. Several […]

Specific targets were not disclosed, but Merck KGaA is betting the artificial intelligence technologies of Exscientia and BenevolentAI will discover into new drugs for cancer, neurology, and immunology.

Shares of Exscientia plc (NASDAQ:EXAI – Get Free Report) shot up 3.5% during mid-day trading on Monday . The company traded as high as $5.32 and last traded at $5.32. 21,115 shares traded hands during trading, a decline of 94% from the average session volume of 339,252 shares. The stock had previously closed at $5.14. […]

Exscientia (NASDAQ:EXAI – Get Free Report) and Omega Therapeutics (NASDAQ:OMGA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Analyst Ratings This is a summary of current […]

Exscientia (NASDAQ:EXAI – Get Free Report) and Repligen (NASDAQ:RGEN – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Analyst Recommendations This is a summary of recent recommendations and […]